Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom

Health Affairs
Steven G MorganDevidas Menon

Abstract

Many countries have centralized the clinical and economic assessments necessary for evidence-based drug coverage policy. We analyze such processes in Australia, Canada, New Zealand, and the United Kingdom. These countries apply comparable approaches to the assessment and appraisal of evidence but apply the processes to different types of drugs and use the reviews within different decision-making contexts. Review processes applied to all medicines and clearly tied to coverage decisions appear to influence national drug use. Rigor of process and transparency of data and rationale are believed to be important for maximizing the impact and political acceptability of the processes.

References

Sep 18, 2001·Health Affairs·A M Garber
Jan 17, 2003·Health Affairs·Norman DanielsJames E Sabin
Jun 5, 2004·International Journal of Technology Assessment in Health Care·Adam OliverRay Robinson

❮ Previous
Next ❯

Citations

Jan 26, 2008·International Journal of Technology Assessment in Health Care·Adam G ElshaugJohn R Moss
Jul 22, 2009·International Journal of Technology Assessment in Health Care·Dan GreenbergJoseph S Pliskin
Apr 16, 2010·International Journal of Technology Assessment in Health Care·Roger ChafeDoug Martin
Dec 24, 2008·BMC Health Services Research·Mireille M GoetghebeurDonna Rindress
Dec 18, 2013·Cost Effectiveness and Resource Allocation : C/E·Angela RocchiRon Goeree
Nov 2, 2007·Australia and New Zealand Health Policy·Adam G ElshaugJohn R Moss
Feb 3, 2011·Healthcare Policy = Politiques De Santé·Andrea C Scobie, Neil J Mackinnon
Feb 13, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Mike TierneyUNKNOWN Members of the Canadian Expert Drug Advisory Committee
Feb 14, 2013·ClinicoEconomics and Outcomes Research : CEOR·Daryl S SpinnerCatherine Copley-Merriman
Feb 21, 2014·PharmacoEconomics·Wannian LiangEric Q Wu
Mar 25, 2014·Health Policy·Sara Mehmood Birchall ShahJohn S F Wright
Mar 29, 2011·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·R Marín-GilJ Bautista-Paloma
Aug 4, 2010·Journal of the American College of Radiology : JACR·Adam G ElshaugJanet E Hiller
Mar 28, 2009·Journal of Health Economics·Jens LudwigKaren Norberg
Feb 26, 2008·British Journal of Clinical Pharmacology·Johan C F van LuijnHubert G M Leufkens
Sep 28, 2015·The International Journal of Risk & Safety in Medicine·Joel Lexchin
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sarah KleijnenWim G Goettsch
Mar 11, 2015·Nature Reviews. Rheumatology·Eric F Morand, Michelle T Leech
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jennifer A Whitty
Sep 15, 2014·Health Policy·Zahava R S Rosenberg-Yunger, Ahmed M Bayoumi
Jun 19, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Katharina E FischerWolf H Rogowski
Aug 26, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Katharina E Fischer, Tom Stargardt
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E Schnipper American Society of Clinical Oncology
Feb 26, 2009·PloS One·David J AgnewTony J Pitcher
Mar 18, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Aris AngelisPanos Kanavos
Sep 11, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Hossein Haji Ali AfzaliTracy Merlin
Sep 6, 2017·International Journal of Technology Assessment in Health Care·Zahra IsmailJeffrey S Hoch
Sep 11, 2008·Health Affairs·Lawrence P CasalinoHoangmai H Pham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.